Cite
HARVARD Citation
Milani, P. et al. (n.d.). High rate of profound clonal and renal responses with daratumumab treatment in heavily pre‐treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate. American journal of hematology. 95 (8), pp. 900-905. [Online].